Luca Gentile

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area

Andrea Cortese, Giuseppe Vita, Marco Luigetti et al. · Journal of Neurology · 2016 · 96 citations

Alzheimer's Disease, Longitudinal Multicenter Study, Non-endemic Area +4

ATTRv amyloidosis Italian Registry: clinical and epidemiological data

Massimo Russo, Laura Obici, Ilaria Bartolomei et al. · Amyloid · 2020 · 84 citations

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area

Anna Mazzeo, Massimo Russo, Gianluca Di Bella et al. · Journal of Neuromuscular Diseases · 2015 · 83 citations · Full text

Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers

Alessandro Salvalaggio, Daniele Coraci, Mario Cacciavillani et al. · Journal of Neurology · 2020 · 61 citations · Full text